menu

HCC

Podcasts

Beyond the Mic: Exploring the Journeys of Leaders.

View All Podcasts arrow

Cholestatic Pruritus Across the Age Spectrum: What Are You Missing?

When considering cholestatic pruritus across the age spectrum, a key point to remember is that while the underlying mechanism is similar, pediatric patients often present with unique challenges in diagnosis and management due to factors like limited communication abilities, potential side effects of medications, and the need for careful dosage adjustments; additionally, older adults might have co-morbidities that complicate treatment and require a more nuanced approach to managing pruritus

Podcasts

cardImg

HCC - New Paradigms in Management

Join Dr. Robert Wong, from Stanford University, Dr. Laura Kulik, from Northwestern, and Dr. Parissa Tabrizian, from Mount Sinai, for an expert discussion on hepatocellular carcinoma (HCC) and the evolving treatment landscape. This high-impact conversation explores how immune checkpoint inhibitors have transformed first-line systemic therapy for HCC, the integration of local regional treatments like Y90 radioembolization, and the growing role of combination strategies, including immunotherapy plus TACE or TKIs. The panel dives into personalized approaches to HCC management, including novel biomarkers, radiomics, and future applications of AI and ctDNA for better patient stratification.

The discussion also highlights expanding liver transplant eligibility through downstaging protocols and the safe use of immunotherapy in pre-transplant settings, as well as the resurgence of living donor liver transplantation. Plus, hear insights into the challenges of post-resection adjuvant therapy and the future of clinical trials in bridging systemic and curative-intent therapies. A must-watch for hepatologists, transplant surgeons, oncologists, and liver disease specialists aiming to stay at the forefront of HCC innovation.
View All Podcasts arrow

Webcasts

cardImg

HCC Connect 2023

Educational Webcast
cardImg

HCC Epidemiology and Care Cascade Recommendations

Educational Webcast
Presented by:
Robert J. Wong, MD, MS
cardImg

New Advances in HCC Therapies

Educational Webcast
Presented by:
Anthony El-Khoueiry, MD
Anjana Pillai, MD
View All Webcasts arrow

Publications

View All Modules arrow
pcbimg

Hepatocellular Carcinoma (HCC) Surveillance Beyond the Guidelines:

Abstract Library

Unlocking Boundless Knowledge Through Abstracts

View All Modules arrow
alcbimg

Real-World Survival Outcomes of Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma Patients With Hepatitis B Virus Infection: A Hospital-Based Cohort Study.

Dung Nguyen Thi (NT);Binh Nguyen Huy (NH);Quang Bui Vinh (BV);Hien Truong Thu (TT);Phuong Pham Cam (PC);Thang Vu Hong (VH)

alcbimg

Glucagon-Like Peptide-1 Receptor Agonists and Hepatocellular Carcinoma Prevention: A Meta-Analysis and Clinical Decision Framework.

Dalbeni Andrea (A);Vicardi Marco (M);Natola Leonardo Antonio (LA);Cattazzo Filippo (F);Auriemma Alessandra (A);Lombardi Rosa (R);Cinque Felice (F);Dalle Carbonare Luca (L);Mantovani Alessandro (A);Sacerdoti David (D)

alcbimg

Getting to Implementation: applying data-driven implementation strategies to improve guideline concordant surveillance for hepatocellular carcinoma.

Yakovchenko Vera (V);Kang Chaeryon (C);Neely Brittney (B);Lamorte Carolyn (C);McCurdy Heather (H);Scott Dawn (D);Nobbe Anna (A);Robins Gwen (G);Ekanem Nsikak R (NR);Merante Monica (M);Gibson Sandra (S);Spoutz Patrick (P);Chia Linda (L);Gonzalez Rachel I (RI);Chinman Matthew J (MJ);Ross David (D);Chartier Maggie (M);Beste Lauren A (LA);Bajaj Jasmohan S (JS);Taddei Tamar (T);Morgan Timothy R (TR);Rogal Shari S (SS)